Most current methods for controlling the rate of formation of a key protein or enzyme in cell 3 factories rely on the manipulation of target genes within the pathway. In this article, we present a 4 novel synthetic system for post-translational regulation of protein levels, FENIX, which provides 5 both independent control of the steady-state protein level and inducible accumulation of targeted 6 proteins. The device is based on the constitutive, proteasome-dependent degradation of the 7 target polypeptide by tagging with a short synthetic, hybrid NIa/SsrA amino acid sequence in the 8 C-terminal domain. The protein degradation process can be reversed by activating the system via 9 addition of an orthogonal inducer (e.g. 3-methylbenzoate) to the culture medium. The system was 10 benchmarked in Escherichia coli by tagging two fluorescent proteins (GFP and mCherry) and 11 further exploited for engineering poly(3-hydroxybutyrate) (PHB) accumulation completely 12 uncoupled from bacterial growth. By tagging PhaA (3-ketoacyl-CoA thiolase, first step of the 13 route), a dynamic metabolic switch at the acetyl-coenzyme A node was established in such a way 14 that this metabolic precursor could be effectively directed into PHB formation upon activation of 15 the system. The engineered E. coli strain reached a very high specific rate of PHB accumulation 16 with a polymer content of ca. 72% (w/w) in glucose cultures set in the growth-decoupled mode. 17 Thus, FENIX enables dynamic control of metabolic fluxes in bacterial cell factories by establishing 18 post-translational synthetic switches in the pathway of interest. 19 20 GRAPHICAL ABSTRACT 21 22 23 24 25 26 27 28 29 5 regulation in cell factories. Transcriptional and translational regulation mechanisms, for instance, 6
One of the main challenges in contemporary metabolic engineering is to develop systems for 3 controlling enzyme activities in a spatial-temporal fashion, leading to the highest possible catalytic Based on these properties, in this work we present FENIX (functional engineering of SsrA/NIa-23 based flux control), a novel tool that merges the two independent degradation systems mentioned 24 above (i.e. tmRNAs and the NIa protease), for the sake of a rapid and convenient in vivo control 25 of protein activities in cell factories. To this end, a synthetic NIa/SsrA tag, which can be easily 26 fused to the C-terminal region of any given protein via a single cloning step in a standardized 27 vector, was engineered to include sequences recognized by both the protease and the 28 proteasome. Unlike other systems for post-transcriptional regulation, the strategy relies on the 29 constitutive degradation of the target followed by its conditional restoration. This system was 30 5 instrumental to bring about an efficient decoupling of PHB accumulation from bacterial growth in 1 recombinant E. coli strains by targeting a key enzyme of the PHA biosynthesis machinery. Rationale of FENIX, a synthetic post-translational control system for pathway engineering. 6 In this work, a novel regulatory system at the post-translational level is presented that repurposes 7 the bacterial proteasome and combines its action with the specific protease NIa, the activity of 8 which can be externally controlled at the user's will. While typical control devices based on 9 proteolysis eliminate specific target proteins 33-35 , the FENIX system presented herein is based in 10 just the i.e. the target is constitutively degraded by default by the endogenous proteasome until 11 the conditional activity of the NIa protease removes the degradation signals and enables 12 accumulation of the protein of interest ( Fig. 1) . To this end a synthetic tag sequence was 13 designed where the recognition sequence of the potyvirus NIa protease (GESNVVVHQADER) 14 was fused to the SsrA target sequence (AANDENYALAA) recognized by the ClpXP and ClpAP 15 components of the bacterial proteasome 36 . The synthetic NIa/SsrA tag 16 (GESNVVVHQADER·AANDENYALAA) can be directly fused to the C-terminal domain of virtually 17 any protein, rendering the polypeptide sensitive to rapid degradation by the proteasome system 18 and abolishing the protein accumulation and/or activity (Fig. 1a) . In the presence of the NIa 19 protease, in contrast, the proteolytic activity cleaves off the NIa/SsrA tag between the Q and A 20 residues of the tagged polypeptide, which will then releases the SsrA target sequence from the C-21 terminus, thereby allowing for protein accumulation and/or enzyme activity ( Fig. 1a) . 22 23 In order to implement this scheme, a novel set of plasmids, based on the structure set by the 24 Standard European Vector Architecture 37-38 , was constructed to facilitate the direct tagging of 25 virtually any protein sequence with the synthetic NIa/SsrA tag ( Fig. 1b ; see details in Methods). 26 FENIX vectors allow for the easy exchange of the gene encoding a fluorescent protein with the 27 coding sequence of the protein of interest upon digestion and ligation with the unique enzyme 28 cutters NheI and BsrGI ( Table 1) . The resulting FENIX plasmid will thus express a nia/ssrA 29 tagged version of the gene of interest under the transcriptional control of the constitutive PtetA 30 promoter. An auxiliary plasmid, termed pS238·NIa, was also constructed for the regulatable 31 expression of the gene encoding the NIa protease by placing the cognate coding sequence under 1 the transcriptional control of the XylS/Pm expression system (Table 1) , inducible upon addition of 2 3-methylbenzoate (3-mBz). With these plasmids at hand, we set out to calibrate the FENIX 3 system as indicated in the next section. 4 5
The FENIX system enables precise control of protein accumulation in recombinant E. coli 6 strains. Our first attempts at calibrating the FENIX system involved two fluorescent reporter 7 proteins, the commonly-used green fluorescent protein (GFP) and the red fluorescent protein 8 mCherry, which have been individually fused to the synthetic nia/ssrA tag in plasmids 9 pFENIX·gfp* and pFENIX·mCherry* [ Table 1 ; note that the asterisk symbol (*) indicates the 10 addition of the synthetic NIa/SsrA tag to the corresponding polypeptide]. Each plasmid was 11 separately transformed along with plasmid pS238·NIa in E. coli DH10B. When either GFP* or 12 mCherry* are produced in E. coli, they will be rapidly degraded by the proteasome, i.e. no green 13 or red fluorescence is to be seen under these conditions. Inspection of the plates in which the E. 14 coli recombinants were streaked under blue light indicated that this was the case, as the colonies 15 had no visually-detectable fluorescence (data not shown). In these strains, inducing the 16 expression of nia from plasmid pS238·NIa would ultimately result in the removal of the SsrA tag, 17 and the proteasome would no longer be able to degrade the fluorescent proteins, which could 18 thus be detected once they accumulate in the cells at sufficient levels. To explore the kinetic 19 properties of the FENIX system, these recombinant E. coli strains were grown in multi-well 20 microtiter plates in LB medium with the antibiotics and additives (3-mBz) indicated in Methods, 21 and bacterial growth and fluorescence (GFP or mCherry) were recorded after 24 h of incubation 22 at 37°C (Fig. 2) .
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The results of population-level fluorescence indicated that the qualitative behavior of the FENIX 25 system was reproducible irrespective of nature of the tagged fluorescent protein. When the 26 tagged GFP* or mCherry* proteins were exposed to the action of the NIa protease, the levels of 27 fluorescence attained after 24 h of cultivation were comparable to those observed in the positive 28 controls, in which the genes encoding the native (i.e. non-tagged) GFP or mCherry proteins were 29 constitutively expressed from the PtetA promoter (Fig. 2) . In the case of GFP*, the final 30 fluorescence levels were ca. 70% of those observed for GFP; for mCherry*, the fluorescence 31 output was ca. 90% of that observed for the non-tagged version of the protein. The FENIX system 1 also exhibited remarkably low levels of either GFP* or mCherry* fluorescence in the absence of 2 3-mBz, which indicates that the (potential) leaky expression of nia does not significantly affect the 3 output fluorescence (i.e. < 10% of the fluorescence levels observed upon induction of the system 4 in both cases)-thereby enabling tight control of protein accumulation. Moreover, and in order to 5 explore the possible effects of the inducer of nia expression (3-mBz) on the behavior of the 6 system, we also measured the specific fluorescence in cultures of E. coli harboring only plasmids 7 pFENIX·gfp* or pFENIX·mCherry* in the presence or the absence of 3-mBz. As indicated in Fig.   8 2, the levels of specific fluorescence in either case were as low as the negative control (i.e. no 9 fluorescent protein), irrespective of the presence of 3-mBz. These quantitative results were 10 mirrored by the fluorescence observed in bacterial pellets of the recombinants harvested from 11 shaken-flask cultures grown under the same conditions ( Fig. 2, lower panel) . Taken together, 12 these results demonstrate that the FENIX system is functional in E. coli under the conditions 13 tested, and that the proposed strategy can be established as a model for synthetic post- The FENIX system enables a precise and concerted temporal switch of protein 18 accumulation. Since the experiments described in the preceding section analyzed the behavior 19 of the FENIX system at the whole-population level, we decided to use E. coli DH10B transformed 20 both with plasmid pS238·NIa and plasmid pFENIX·gfp* in a set of experiments aimed at an in-21 depth characterization of the FENIX system at the single-cell level (Fig. 3) . In this case, the 22 recombinants were grown in LB medium in shaken-flask cultures under the same culture 23 conditions used in the experiments carried out in microtiter-plate cultures, and samples were 24 periodically taken to analyze the levels of GFP* fluorescence by flow cytometry. At the first data 25 point, taken at 3 h post-induction of the system by the addition of 3-mBz at 1 mM, the induced 26 (i.e. GFP*-positive) bacterial culture behaved as a single population (i.e. characterized by a single in these experiments). These results accredit the versatility of the FENIX system to externally 18 control the accumulation of a target protein in a tightly regulated, and temporally coordinated 19 fashion. Once the calibration of the system was complete, we exploited FENIX for tackling a 20 longstanding problem in metabolic engineering of biopolymers as disclosed below. expressed during the active growth phase. On the other hand, acetyl-CoA is a hub metabolite in 10 the cell, used as a precursor by a large number of metabolic pathways, and achieving precursor 11 levels leading to high levels of PHB accumulation is inherently difficult considering the number of 12 competing routes that also use acetyl-CoA. We hypothesized that the efficient uncoupling of 13 bacterial growth and biopolymer accumulation could be an alternative for efficient PHB 14 biosynthesis. Accordingly, the FENIX system was adapted to artificially control the level (and The PhaA activity can be tightly regulated by means of the FENIX system. E. coli BW25113, 26 a well characterized wild-type strain 44 , was transformed with plasmids pS238·NIa and 27 pFENIX·PHA* ( Table 1) . Plasmid pFENIX·PHA* expresses the phaC1AB1 gene cluster of C. 28 necator from its own constitutive promoter, and contains a variant of phaA fused to the nia/ssrA-29 tag sequence (Fig. 4b) . Shaken-flask cultures of this recombinant strain were carried out in LB 30 medium containing 30 g L -1 glucose, and growth parameters, PHB accumulation and the in vitro 31 1 can be switched on by means of the FENIX system. In non-induced cultures (i.e. without addition 2 of 3-mBz), the levels of 3-ketoacyl-CoA thiolase activity consistently remained below 2 μmol min -1 3 mgprotein -1 throughout the cultivation (Fig. 5a) . This background thiolase activity was also detected 4 in E. coli BW25113 transformed only with plasmid pS238·NIa, and can be accounted for by the 5 endogenous ketoacyl-CoA thiolases of E. coli (e.g. AtoB and FadA). In contrast, when 3-mBz was 6 added to the cultures at 1 mM, a quick and sharp increase in the in vitro PhaA activity was 7 detected, reaching a 30-fold higher level at 8 h post-induction. By 24 h of cultivation, the PhaA 8 activity in induced cultures had reached 6.1  0.7 μmol min -1 mgprotein -1 . In a parallel experiment, 9 E. coli BW25113/pS238·NIa was transformed either with plasmids pAeT41 or pS341·PHA, which 10 constitutively express the native phaC1AB1 gene cluster of C. necator (in the latter case, in the 11 same vector backbone used for FENIX plasmids, i.e. pSEVA341). The in vitro PhaA activity was 12 measured in 24-h cultures of these recombinant strains under the same growth conditions 13 indicated above, in the absence of presence of 3-mBz ( Fig. 5b) . E. coli BW25113/pS238·NIa 14 transformed either with plasmids pAeT41 or pS341·PHA had similarly high levels of PhaA activity 15 irrespective of the presence of 3-mBz. In contrast, a clear difference in the thiolase activity was 16 detected in E. coli BW25113 transformed both with plasmids pS238·NIa and pFENIX·PHA*. In 17 non-induced cultures, the enzymatic activity remained at levels < 1 μmol min -1 mg protein -1 even 18 after 24 h of cultivation, but the addition of 3-mBz triggered an 8-fold increase in PhaA activity.
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Moreover, the activity in the induced cultures carrying the PhaA* variant reached the highest 20 levels among all experimental strains and conditions. The tighter control of protein accumulation 21 afforded by the FENIX system thus contributes to 1.6-fold higher activity levels of the tagged 22 enzyme as compared to the native PhaA.
24
The levels of PHB accumulation were also inspected in these cultures by means of flow 25 cytometry and gas chromatography as indicated in Methods. The content of PHB in the bacterial 26 biomass closely mirrored the levels of PhaA activity in all recombinants ( Fig. 5c) . Again, induced cultures of the strain carrying the NIa/SsrA-tagged variant of PhaA exhibited the highest 28 polymer content on a cell dry weight (CDW) basis [56.2%  6.1% (w/w), 7-fold higher than that in 29 non-induced cultures] among all strains tested. Importantly, all the strains grew at similar levels 30 (with a final biomass density of ca. 5 gCDW L -1 at 24 h), indicating that the differences observed in 31 1 brought about by the FENIX system and not to any effect on bacterial growth. 2 3
The FENIX system enables efficient decoupling of PHB biosynthesis and bacterial growth 4 and leads to high rates of biopolymer accumulation. In order to gain further insights into the 5 dynamics of PHB accumulation in our recombinant E. coli strains in shaken-flask cultures, we 6 carried out a thorough physiological characterization in M9 minimal medium containing 30 g L -1 7 glucose as the sole carbon source (Fig. 6) . To this end, bacterial growth and PHB accumulation 8 were closely monitored over 24 h in batch cultures of E. coli BW25113/pS238·NIa carrying either 9 plasmid pS341·PHA (native PhaA) or pFENIX·PHA* (NIa/SsrA-tagged PhaA). The growth of the 10 two strains was comparable, and the final biomass density plateaued at ca. 3.5 gCDW L -1 ( Fig. 6a ).
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The trajectory of PHB accumulation, in contrast, differed between the two strains ( Fig. 6b) . In E. Next, we assessed the specific rate of bacterial growth and biopolymer accumulation ( Fig. 6c) . 22 The specific growth rate (μ), as inferred from the growth curves, was not significantly different 23 between the two E. coli recombinants (ca. 0.3 h -1 ). However, the clear decoupling of PHB 24 accumulation from bacterial growth in the strain carrying the PhaA* variant resulted a 2-fold 25 higher specific rate of PHB accumulation (rPHB). Under these experimental conditions, rPHB = 0.41 26  0.02 h -1 , which is the highest reported in the literature for recombinant E. coli strains. The 27 growth decoupling effect was also visually evidenced when cells were sampled from these 28 cultures, stained with the lipophilic Nile Red dye, and observed under the fluorescence 29 microscope ( Fig. 6d) . Upon induction of the FENIX system, the rapid accumulation of PHB in the 30 recombinants could be clearly detected as the polymer granules started to fill the bacterial 31 cytoplasm. Taken together, these results suggest that the FENIX system can be used as a 1 metabolic switch operating at the acetyl-CoA metabolic node-a possibility that was explored in 2 detail as explained below.
3 4 Enhanced PHB accumulation mediated by PhaA* stems from flux re-wiring around the 5 acetyl-CoA node. As indicated previously, acetyl-CoA is a metabolic hub in the cell. In the E. coli 6 recombinants described in this work, a major competition occurs at this node between the PHB 7 biosynthesis pathway and other endogenous metabolic routes. Apart from the core cell functions 8 that use acetyl-CoA as building-block (e.g. de novo fatty acid synthesis), in the presence of 9 excess glucose, E. coli synthesizes (and excretes) acetate from acetyl-CoA through a two-step 10 route catalyzed by Pta (phosphotransacetylase) and AckA (acetate kinase) 45 (Fig. 7a) . Taking 11 advantage of this biochemical feature, we adopted the specific rate of acetate formation and the 12 content of acetyl-CoA as a proxy to gauge how the FENIX system could re-direct this metabolic 13 precursor into a target pathway. A lower specific rate of acetate formation was detected in 14 glucose cultures of all E. coli strains expressing the PHB biosynthesis pathway as compared to 15 the control strain, transformed with the empty pSEVA341 vector (Fig. 7b )-consistent with a 16 higher flux of acetyl-CoA going into PHB formation. However, E. coli BW25113/pS238·NIa 17 transformed with plasmid pFENIX·PHA* had the lowest rate of acetate synthesis along all the 18 strains tested (0.9  0.1 mmol gCDW -1 h -1 ; 70% lower than that of the control strain). Interestingly, 19 when the specific rates of glucose consumption were also determined in these cultures, no major 20 differences were observed among all the strains (with qS values around 7-8 mmol gCDW -1 h -1 ), 21 indicating that the differences in acetate formation or PHB accumulation are linked to a re-routing 22 of acetyl-CoA rather than to significant changes in the overall cell physiology.
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The intracellular acetyl-CoA content qualitatively followed the same trend as the specific rates of 25 acetate formation, although the values obtained for this parameter were comparable among the 26 control strain and the E. coli recombinants expressing the native phaC1AB1 gene cluster ( Fig.   27 7c). Again, the tight control of the PHB biosynthesis pathway at the level of PhaA afforded by the 28 FENIX system was reflected in the lowest content of acetyl-CoA among all the strains tested 29 (0.23  0.05 nmol gCDW -1 )-suggesting an efficient re-routing of this metabolic precursor into PHB 30 accumulation rather than into other metabolic sinks of acetyl-CoA. These results accredit that the 31 1 biochemical network, acting as a switch to re-route the fluxes around such nodes towards the 2 formation a product of interest. Bacterial strains and cultivation conditions. The E. coli strains and plasmids used in this study 28 are listed in Table 1 . E. coli was grown at 37ºC in LB medium 46 or in M9 minimal medium 47 added 29 with glucose (30 g L -1 ) as the sole carbon source. For solidified culture media, 1.5% (w/v) agar 30 was used. Shaken-flask cultivations were routinely carried out in an air incubator with orbital 31 shaking at 200 rpm. Aerobic cultures were set by using a 1:10 culture medium-to-flask volume 1 ratio. Antibiotics were added to the cultures where appropriate at the following final 2 concentrations: ampicillin (Ap, 150 mg L -1 ), chloramphenicol (Cm, 30 mg L -1 ), and kanamycin 3 (Km, 50 mg L -1 ). Sigma-Aldrich Co. The identity of all cloned inserts and DNA fragments was confirmed by DNA 10 sequencing through an ABI Prism 377 automated DNA sequencer (Applied Biosystems Inc.).
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Transformation of E. coli cells with plasmids was routinely carried out by means of the RbCl 12 method or by electroporation 48 (Gene Pulser, Bio-Rad). Table 1) . The same procedure was repeated with the gene encoding GFP, 6 yielding pFENIX·gfp* ( Table 1) . Both plasmids were used to calibrate the FENIX system, and 7 they allow for the easy construction of a proteolizable version of virtually any protein by a direct 8 cloning step of the corresponding gene of interest into the NheI and BsrGI restriction sites that 9 flank the fluorescent protein coding sequence. Two expression vectors were also constructed as positive controls of the FENIX system. In order 12 to stablish a direct comparison between the fluorescence originated by the engineered GFP* or 13 mCherry* fluorescent proteins after proteolysis, we designed and created a version of these two 14 proteins that have the same amino acid sequence as the proteolizable variants after digestion by 15 the NIa protease. Plasmid pS341T·mCherry*, encoding such an engineered mCherry protein, 16 was constructed by amplifying the mCherry gene plus the short sequence of the nia target that 17 remains after protease digestion using oligonucleotides 5'-mCherry·NheI (5'-CAC AGG AGG 18 GCT AGC ATG GTG AG-3'; an engineered NheI site is underlined) and 3'-mCherry·HindIII (5'-19 GGG AAG CTT TTA CTG ATG CAC CAC CAC GTT GCT TTC-3'; an engineered HindIII site is 20 underlined) by using plasmid pFENIX·mCherry* as the template. The resulting amplicon, which 21 spans the sequence encoding the mCherry protein after proteolysis, was restricted with the 22 enzymes indicated and cloned into the NheI/HindIII-digested pS341T vector, thereby obtaining 23 plasmid pS341T·mCherry* ( Table 1) . The same procedure was repeated for GFP, yielding 24 plasmid pS341T·gfp* ( Table 1) . necator, the strategy used for tagging this gene was slightly different as the one described above 29 for single-gene targets. In this case, the synthetic nia/ssrA tag was firstly added to phaA by 30 overlapping PCR. Two individual DNA fragments upstream and downstream with respect to the 31 1 GCG GCA AGA TCT CGC AGA CC-3'; an engineered BglII site is underlined) and 3'-phaA·nia 2 (5'-cgt cgt ttg ctg cgc gtt cat ccg cct gat gca cca cca cgt tgc ttt cac cTT TGC GCT CGA CTG 3 CCA GCG C-3') for the upstream fragment (2,462 bp) and (ii) 5'-phaA·nia (5'-gca tca ggc gga tga 4 acg cgc agc aaa cga cga aaa cta cgc ttt agc agc tTA AGG AAG GGG TTT TCC GGG GC-3') and the cells in a side scatter against forward scatter plot, and then the GFP-associated fluorescence 31 was recorded in the FL1 channel (515-545 nm). Data processing was performed using the 1 FlowJo TM software as described elsewhere 50 .
3
In vitro quantification of the PhaA activity. Cell-free extracts were obtained from bacteria 4 harvested by centrifugation (4,000g at 4°C for 10 min). Cell pellets were resuspended in 1 mL of 5 a lysis buffer containing 10 mM Tris·HCl (pH = 8.1), 1 mM EDTA, 10 mM β-mercaptoethanol, 6 20% (v/v) glycerol, and 0.2 mM phenylmethylsulphonylfluoride, and lysed as described Biol. Chem. 1989, 264 (26) , 15298-15303. 
